
|Articles|February 3, 2022
Daily OTC Pearl: PreserVision
Author(s)Saro Arakelians, PharmD
PreserVision is a supplement that may help lower the risk of progression of moderate-to-advanced age-related macular degeneration.
Advertisement
OTC/Lifestyle Pearl of the Day: PreserVision
Indication: PreserVision is a nutritional supplement for ocular health.
Insight:
- Vitamin A (as beta carotene) 14,320 IU, vitamin C (as ascorbic acid) 226mg, vitamin E 200 IU, copper (as cupric oxide) 0.8mg, zinc (as oxide) 34.8mg; per softgel; contains gelatin, soy.
- Adult dosage: 1 softgel twice daily (am and pm) with meals.
- PreserVision AREDS2 contains a nutrient formula that is recommended by the National Eye Institute to help lower the risk of progression in people with moderate-to-advanced age-related macular degeneration.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
Notable Updates in Medication Therapy Management in 2025
4
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
5









































































































































































































